SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-004870
Filing Date
2017-05-08
Accepted
2017-05-08 17:30:02
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 648641
2 ex4-3.htm EX-4.3 60736
3 ex4-4.htm EX-4.4 60457
4 ex10-2.htm EX-10.2 81050
5 ex31-1.htm EX-31.1 15574
6 ex32-1.htm EX-32.1 8463
  Complete submission text file 0001493152-17-004870.txt   4785796

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ppch-20170331.xml EX-101.INS 650588
8 XBRL SCHEMA FILE ppch-20170331.xsd EX-101.SCH 51008
9 XBRL CALCULATION FILE ppch-20170331_cal.xml EX-101.CAL 54123
10 XBRL DEFINITION FILE ppch-20170331_def.xml EX-101.DEF 214820
11 XBRL LABEL FILE ppch-20170331_lab.xml EX-101.LAB 356154
12 XBRL PRESENTATION FILE ppch-20170331_pre.xml EX-101.PRE 275503
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 17823603
SIC: 2834 Pharmaceutical Preparations